Pursuing the first Investigational New Drug (IND) for Rett syndrome: Neuren Pharmaceuticals announces a program to the FDA about a proposed Rett syndrome clinical trial

http://www.rettsyndrome.org/flash/Research-Flash_online_050912.html


Source: International Rett Syndrome Foundation